A Study of GSK5764227 in People With Gastrointestinal Solid Tumors

Full Title

A Phase 1b/2, Multicenter, Randomized, Open-label Study to Evaluate the Efficacy and Safety of GSK5764227 Alone and in Combination in Participants with Previously Treated Advanced Unresectable or Metastatic Gastrointestinal Solid Tumors

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Andrea Cercek’s office at 646-888-4189.